Affle to acquire Perion, to scale its CPCU business across Developed markets

Affle’s subsidiary agreed to acquire all outstanding Perion shares for $11.70 per share in cash, implying an equity value of about $420 million. The deal, subject to regulatory and Perion shareholder approvals and a go-shop period, is expected to close in early 2027; Perion had about $228 million in cash and no financial debt as of September 30, 2026. Affle expects the acquisition to be EPS-accretive by the end of the first year after closing and forecasts a FY2028 revenue run rate above $700 million.

Analysis

The key underwriting question is not whether the combined platform sounds broader, but whether Affle can convert Perion’s upper-funnel inventory into incremental, attributable outcomes without weakening customer economics. The proposed CPCU shift could improve the quality of revenue and profitability, but contract reviews and changed revenue recognition may also make reported sales and growth less comparable. Require pro forma gross profit, cash conversion, retention, and like-for-like revenue bridges before crediting the accretion claim.

For Perion, the cash offer anchors value, but the investable spread depends on its live price and deal terms; neither is provided. The go-shop creates some bid optionality, while regulatory/shareholder approvals and a close expected in early 2027 leave time for spread volatility and execution risk. Perion’s cash balance may reduce the effective acquisition burden, but verify closing-date cash, transaction costs, financing commitments, and any termination provisions.

Near term, expect event-driven trading to dominate fundamentals. Over 1–3 months, proxy materials, go-shop outcome, and financing/approval details are the catalysts. Over 6–18 months, the test is advertiser retention and measurable conversion economics across CTV, retail media, and DOOH—not platform breadth alone. Independent ad-tech providers face a tougher cross-channel pitch if integration works; large walled gardens remain formidable substitutes. The contrarian risk is that investors capitalize promised synergies before evidence, while underestimating integration and measurement friction. Affle’s stated net-debt-free position and FY2028 revenue run rate are company projections, not verified outcomes.

Key Decisions for Investors

• PERI: Treat as a deal-arbitrage watch, not an unconditional buy. Compare the market price with US$11.70 and calculate annualized spread after time-to-close and break risk; avoid initiating if the spread is too narrow to compensate for an early-2027 close.
• PERI: Reassess after go-shop results and definitive proxy disclosures. Falsifiers include a competing offer, shareholder opposition, material regulatory conditions, or evidence of customer/employee attrition during the pendency period.
• Affle 3i: Do not pay for projected synergies on announcement alone. Seek audited pro forma economics, funding terms, and a bridge separating revenue-recognition effects from genuine margin and cash-flow improvement; reassess if leverage or integration costs undermine the stated net-debt-free outcome.
• Watch the first post-close reporting cycle for advertiser retention, conversion outcomes, gross profit, and cash conversion. If reported revenue changes materially under CPCU, compare underlying economics rather than headline growth or sales multiples.